Financial Performance - For the year ended December 31, 2024, the investment income was 122,631 in 2023, primarily due to interest accrued on Hera[183]. - Operating expenses for the year ended December 31, 2024 totaled approximately 1,583,768 in 2023, mainly due to a decrease in total net assets[186]. - The net investment income for the year ended December 31, 2024 was 1,081,579 in 2023, primarily due to a waiver of investment advisory fees[190]. - The net decrease in net assets resulting from operations for the year ended December 31, 2024 was 29,349,220 decrease in 2023[200]. - The total cash reserves and liquid securities decreased approximately 80% in 2024, primarily due to the sale of portfolio securities and operating expenses[206]. - Realized losses for the year ended December 31, 2024 were approximately 7,864,982 losses in 2023, primarily due to the sale of investments[193]. - The net unrealized depreciation on total investments decreased by 1.1 million, with a NAV per share of 29 thousand, consisting of 1,930,000 shares of Series A preferred stock and 100,000 shares of common stock[211]. - The investment in IntraOp Medical Corporation included 26,856,187 shares of Series C preferred stock and various convertible notes, with a combined aggregate fair value of approximately 260 thousand[217]. - The investment in Wrightspeed, Inc. included 60,733,693 shares of Series AA preferred stock and multiple convertible notes, with a combined fair value of approximately 745 thousand, consisting of 745,224 shares[223]. Capital Management - The company expects to raise additional capital through future equity offerings to support growth, which may lead to dilution for existing investors if offered below NAV[209]. - The company intends to distribute at least 90% of its ordinary income and realized net short-term capital gains annually to qualify as a RIC and avoid corporate-level tax[224]. - The Company is required to distribute substantially all net realized gains to shareholders annually, holding proceeds of liquidated investments in cash pending distribution[246]. Legal and Compliance - The company does not have any contractual obligations or off-balance sheet arrangements that require disclosure[225][226]. - The company has evaluated subsequent events and intends to vigorously defend against allegations in ongoing legal complaints[234][236]. - The company believes that the impact of recently issued accounting standards will not have a material impact on its financial statements[231]. Financial Reporting - The consolidated financial statements present fairly the financial position of the Company as of December 31, 2024 and 2023, in conformity with generally accepted accounting principles[247]. - The Company announced approval to withdraw its BDC election and pursue liquidation[252]. Risk Management - As of December 31, 2024, a significant portion of the Fund's assets is held in cash and/or cash equivalents, which are expected to earn low yields[244]. - The Fund may experience losses if management fees and operating expenses exceed interest income from cash holdings[244]. - The company measures realized gains or losses based on the difference between net proceeds from the sale and the cost basis of the investment[230].
Firsthand Technology(SVVC) - 2024 Q4 - Annual Report